Physician profile
Alan D Goldsmith
NPI 1891781795
$1,679.38
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $296 · 2021: $549 · 2024: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $142.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $392.48 | 2019-2021 | |
| Hologic Sales and Service, LLC | $185.99 | 2019-2024 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Aspira Women'S Health INC | $165.29 | 2020-2021 | |
| Astellas Pharma US INC | $127.09 | 2020-2021 | |
| Amgen INC. | $95.71 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $73.86 | 2019 | |
| Evofem Biosciences, INC. | $72.68 | 2020-2021 | |
| Lupin INC. | $72.27 | 2019-2020 | |
| Allergan, INC. | $65.43 | 2019-2020 | |
| Therapeuticsmd, INC. | $57.20 | 2019-2020 | |
| Myovant Sciences INC. | $47.77 | 2021 | |
| Daiichi Sankyo INC. | $46.56 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $43.58 | 2019 | |
| Merck Sharp & Dohme LLC | $41.86 | 2019-2021 | |
| Coopersurgical, INC. | $33.33 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $21.27 | 2020 | |
| Becton, Dickinson and Company | $17.50 | 2019 | |
| Ascend Therapeutics US, LLC | $17.23 | 2020 | |
| Acessa Health INC. | $17.22 | 2019 | |
| Exeltis, USA INC. | $16.32 | 2019 | |
| Medicem INC. | $15.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2019 | |
| Mayne Pharma Commercial LLC | $13.78 | 2021 | |
| Boston Scientific Corporation | $13.37 | 2019 | |
| Duchesnay USA Incorporated | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Goldsmith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.